139 related articles for article (PubMed ID: 8811381)
1. Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study.
Soslow RA; Chung MH; Rouse RV; Hendrickson MR; Longacre TA
Int J Gynecol Pathol; 1996 Jul; 15(3):209-16. PubMed ID: 8811381
[TBL] [Abstract][Full Text] [Related]
2. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
3. Stromal p16 Expression Helps Distinguish Atypical Polypoid Adenomyoma From Myoinvasive Endometrioid Carcinoma of the Uterus.
Kihara A; Amano Y; Yoshimoto T; Matsubara D; Fukushima N; Fujiwara H; Niki T
Am J Surg Pathol; 2019 Nov; 43(11):1526-1535. PubMed ID: 31600177
[TBL] [Abstract][Full Text] [Related]
4. Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
Worrell HI; Sciallis AP; Skala SL
Histopathology; 2021 Jul; 79(1):96-105. PubMed ID: 33459390
[TBL] [Abstract][Full Text] [Related]
5. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases.
Longacre TA; Chung MH; Rouse RV; Hendrickson MR
Am J Surg Pathol; 1996 Jan; 20(1):1-20. PubMed ID: 8540600
[TBL] [Abstract][Full Text] [Related]
6. Lesion-targeted cytology to improve cytological sampling for atypical polypoid adenomyomas of the uterus: A case series and review of the literature.
Omori M; Kawai M; Ogawa T; Sasatsu S; Fukasawa H; Nakazawa K; Kondo T; Hirata S
Cytopathology; 2020 Nov; 31(6):579-585. PubMed ID: 32779225
[TBL] [Abstract][Full Text] [Related]
7. Stromal p16 and SATB2 Expression Does Not Distinguish Atypical Polypoid Adenomyoma (APA) From its Benign Mimics.
Bui CM; Azimpouran M; Balzer B; Maluf H; Medeiros F
Int J Gynecol Pathol; 2024 May; ():. PubMed ID: 38833724
[TBL] [Abstract][Full Text] [Related]
8. Atypical polypoid adenomyoma of the uterus: A reappraisal of the clinicopathological and immunohistochemical features.
Lu B; Yu M; Shi H; Chen Q
Pathol Res Pract; 2019 Apr; 215(4):766-771. PubMed ID: 30661903
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical characteristics of atypical polypoid adenomyoma with special reference to h-caldesmon.
Horita A; Kurata A; Maeda D; Fukayama M; Sakamoto A
Int J Gynecol Pathol; 2011 Jan; 30(1):64-70. PubMed ID: 21131830
[TBL] [Abstract][Full Text] [Related]
10. Coexistent atypical polypoid adenomyoma and endometrial adenocarcinoma.
Mittal KR; Peng XC; Wallach RC; Demopoulos RI
Hum Pathol; 1995 May; 26(5):574-6. PubMed ID: 7750942
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma.
Zhu XQ; Shi YF; Cheng XD; Zhao CL; Wu YZ
Gynecol Oncol; 2004 Jan; 92(1):71-9. PubMed ID: 14751141
[TBL] [Abstract][Full Text] [Related]
12. Atypical polypoid adenomyoma of the uterus: an immunohistochemical study on 5 cases.
Terada T
Ann Diagn Pathol; 2011 Oct; 15(5):338-41. PubMed ID: 21684185
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotype of Atypical Polypoid Adenomyoma of the Uterus: Diagnostic Value and Insight on Pathogenesis.
Travaglino A; Raffone A; Saccone G; Fuggi M; De Placido G; Mascolo M; Mollo A; Insabato L; Zullo F
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):646-653. PubMed ID: 31855579
[TBL] [Abstract][Full Text] [Related]
14. Coexistent atypical polypoid adenomyoma and complex atypical endometrial hyperplasia in the uterus.
Horita A; Kurata A; Komatsu K; Yajima M; Sakamoto A
Diagn Cytopathol; 2010 Jul; 38(7):527-32. PubMed ID: 19950396
[TBL] [Abstract][Full Text] [Related]
15. Multiple atypical polypoid adenomyoma of the uterus.
Horikawa M; Shinmoto H; Soga S; Shiomi E; Sei K; Shimazaki H; Kaji T
Jpn J Radiol; 2012 Aug; 30(7):606-11. PubMed ID: 22684616
[TBL] [Abstract][Full Text] [Related]
16. Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis.
Aggarwal N; Bhargava R; Elishaev E
Int J Gynecol Pathol; 2012 Sep; 31(5):447-52. PubMed ID: 22833085
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of endometrioid adenocarcinoma in atypical polypoid adenomyoma.
Sonoyama A; Kanda M; Ojima Y; Kizaki T; Ohara N
Kobe J Med Sci; 2014 Dec; 60(3):E74-7. PubMed ID: 25612673
[TBL] [Abstract][Full Text] [Related]
18. Significance of stromal markers in atypical polypoid adenomyoma.
Travaglino A; Raffone A; Gencarelli A; Zullo F; Di Spiezio Sardo A; Insabato L
Pathol Res Pract; 2020 Nov; 216(11):153133. PubMed ID: 32823231
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of atypical polypoid adenomyoma.
Yamashita Y; Torashima M; Hatanaka Y; Takahashi M; Fukumatsu K; Tanaka N; Miyazaki K; Okamura H
Comput Med Imaging Graph; 1995; 19(4):351-5. PubMed ID: 8653672
[TBL] [Abstract][Full Text] [Related]
20. [Menorrhagia as a consequence of atypical polypoid adenomyoma in uterus].
Foss Hansen MF; Marcussen Skovby BD
Ugeskr Laeger; 2012 May; 174(21):1464-5. PubMed ID: 22640791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
